Cargando…
Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana
BACKGROUND: Plasmodium vivax malaria is a major public health problem in French Guiana. Some cases of resistance to chloroquine, the first-line treatment used against P. vivax malaria, have been described in the Brazilian Amazon region. The aim of this study is to investigate a possible dispersion o...
Autores principales: | Faway, Emilie, Musset, Lise, Pelleau, Stéphane, Volney, Béatrice, Casteras, Jessica, Caro, Valérie, Menard, Didier, Briolant, Sébastien, Legrand, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101641/ https://www.ncbi.nlm.nih.gov/pubmed/27825387 http://dx.doi.org/10.1186/s12936-016-1595-9 |
Ejemplares similares
-
Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana
por: Musset, Lise, et al.
Publicado: (2019) -
Absence of correlation between ex vivo susceptibility to doxycycline and pfteQ–pfmdt gene polymorphism in French Guiana
por: Mura, Marie, et al.
Publicado: (2015) -
Genetic diversity of msp3α and msp1_b5 markers of Plasmodium vivax in French Guiana
por: Véron, Vincent, et al.
Publicado: (2009) -
Malaria on the Guiana Shield: a review of the situation in French
Guiana
por: Musset, Lise, et al.
Publicado: (2014) -
High Performance of Histidine-Rich Protein 2 Based Rapid Diagnostic Tests in French Guiana are Explained by the Absence of pfhrp2 Gene Deletion in P. falciparum
por: Trouvay, Mélanie, et al.
Publicado: (2013)